USPTO serial 87776246
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Transparency Life Sciences, Inc.
New York, NY
Transparency Life Sciences, Inc.
New York, NY
Transparency Life Sciences, Inc.
New York, NY
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210-2206UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing online non-downloadable computer software for planning, management and operational management in the field of clinical trials; providing online non-downloadable computer software for crowdsourcing data and information for clinical trials; providing online non-downloadable computer software for collecting, managing, and analyzing data related to crowdsourcing and crowdsharing in the field of clinical trials; providing online non-downloadable computer software for collecting data from clinical trials, for database management in the field of clinical trials; providing online non-downloadable computer software for the management of data from clinical trials; providing online non-downloadable computer software to enable the capture, reporting, and processing of data in pharmaceutical industry clinical trials; providing temporary use of online, non-downloadable, internet-based software for use in clinical trial project management and clinical trial data management; providing online non-downloadable software for planning, managing and operational support of clinical trials; scientific consulting services in the field of conducting clinical trials, and research and development of pharmaceuticals, biopharmaceuticals, and medical devices; clinical research for others in the fields of oncology, cardiology, virology, and infectious disease for the production of pharmaceuticals, biopharmaceuticals, and medical devices, and for the ultimate regulatory approval and registration of the foregoing goods; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial and drug development information; hosting and providing temporary use of online non-downloadable software for use in connection with the collection, review, analysis, and reporting of clinical trial and drug development information; pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of pharmaceuticals and clinical trials | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 26, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 24, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 24, 2019 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 26, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 27, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 7, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 24, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 24, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 24, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 7, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |